Speakers - BIO International Convention

VICE PRESIDENT OF REAL ESTATE, UNIVERSITY CITY SCIENCE CENTER

Building Bio Facilities and Bio Ecosystems: Federal, State and Private Resources

Philadelphia, Pennsylvania, United States

VP & BUSINESS HEAD, CELL THERAPY, RESILIENCE

Therapeutic Cell and Gene Therapy Modalities - Business and Manufacturing Strategies Impacting the Decision to Develop One Therapy Type vs. Another

La Jolla, California, United States

Tony Adame

DIRECTOR, AON

Supply chain crisis: forward looking solutions

Irvine, California, United States

Cary Adams, MBA

CHIEF EXECUTIVE OFFICER, UNION FOR INTERNATIONAL CANCER CONTROL (UICC)

Changing the Paradigm: Expanding Access to Oncology Medicines

Geneva,

Maddalena Adorno, PhD

CHIEF EXECUTIVE OFFICER AND CO-FOUNDER, DORIAN THERAPEUTICS

Dorian Therapeutics

San Carlos, California, United States

Jyoti Agarwal

MANAGING DIRECTOR, COQUAL

Best Practices for Building an Inclusive Biotech Company

Muhammad Al Hajj

MR, IO BIOTECH USA

Early Scientific and Clinical Strategy for Optimizing Value Inflection in Oncology Financing and Dealmaking

Rockville, Maryland, United States

Olivia Albrecht

CHIEF SUSTAINABILITY OFFICER, ASPIRATION

Harnessing the Power of Biotechnology on ESG Issues

Newport Beach, California, United States

Esther Alegria, PhD

CEO, APIE THERAPEUTICS

APIE Therapeuctics

Durham, North Carolina, United States

Debbie Alexander, DPhil

DIRECTOR, BUSINESS DEVELOPMENT, 23ANDME

Monetizing AI & Machine Learning Applications in Life Sciences

Sunnyvale, California, United States

Meg Alexander

CHIEF CORPORATE AFFAIRS OFFICER, OVID THERAPEUTICS INC.

Diversity and Inclusion in Clinical Trials: Concrete Strategies for Enhancing Health Equity

New York, New York, United States

Kevin Ali

CHIEF EXECUTIVE OFFICER, ORGANON

Primed for Growth: Innovating to Address the Business Opportunity to Build a Women’s Health Market

Jersey City, New Jersey, United States

Gordon Alton

CEO, BRIORI BIOTECH

Briori Biotech

Carlsbad, California, United States

Ruben Amarasingham

CEO, DALLAS TEXANS

The Roles of AI and Big Data in Precision Healthcare: Perspectives from the Drug Development Pathway and the Patient Journey

Dallas, Texas, United States

Amin Al Amiri

ASSISTANT UNDERSECRETARY OF HEALTH REGULATION SECTOR, MOHAP, UAE

Spurring Biotech Innovation Across The Globe: A High-Level Discussion

Roee Amit

CHIEF TECHNOLOGY OFFICER, BENEVIRA

Benevira

New York, New York, United States

Erin Andrews

Wednesday Keynote: Conversation Featuring Venus Williams and Erin Andrews

Lindsay Androski

CEO, ROIVANT SOCIAL VENTURES, ROIVANT SCIENCES, INC.

Biopharma Sustainability: Multilateral Guidance on Strategy, Opportunity, and Risk

New York, New York, United States

David Apelian, MBA;MD;PhD

CEO, BLUESPHERE BIO, INC.

BlueSphere Bio

Pittsburgh, Pennsylvania, United States

Katelyn Arnold, PhD

PRINCIPAL SCIENTIST, GLYCAN THERAPEUTICS

Glycan Therapeutics

Raleigh, North Carolina, United States

Judy Ashworth, MD

CHIEF MEDICAL OFFICER, PINNEY ASSOCIATES

Ceruvia Lifesciences, Inc.

Greenwich, Connecticut, United States

Mara Aspinall

FOUNDER & MANAGING DIRECTOR, BLUESTONE VENTURE PARTNERS

Defining Correlates of Protection for COVID-19: The Technology is Here, The Time is Now

Tucson, Arizona, United States

Basel Assaf, BVSc;DACVP;PhD

DISTINGUISHED SCIENTIST, SANOFI GENZYME

Safety Aspects of AAV- and Lentivirus-based Cell and Gene Therapy

Waltham, Massachusetts, United States

Trond Erik Aune, PhD

CEO, VECTRON BIOSOLUTIONS AS

Vectron Biosolutions AS

Trondheim, Norway

Richard Austin

CEO, REGLAGENE

Reglagene

Tucson, Arizona, United States

Shara Avis Pecoraro, MHA

MANAGER, STRATEGIC INDUSTRY VENTURES, UNIVERSITY OF TEXAS, MD ANDERSON CANCER CENTER

Cancer Trials Don’t Have To Fail 90% of the Time. Seriously.

Houston, Texas, United States

Suzanne Babcock

CHAIRMAN AND CEO, CIVATECH ONCOLOGY

CivaTech Oncology

Research Triangle Park, North Carolina, United States

Martin Babler

PRESIDENT & CEO, ALUMIS, INC.

How to Survive a Stormy Biotech Season: Thriving in a Challenging Market

South San Francisco, California, United States

Mark Bach, MD;PhD

CHIEF MEDICAL OFFICER, SHOUTI INC.

Ending The Cycle of Chronic Disease: Leveraging New Therapeutic Approaches with Disease-Modifying Potential

Scotch Plains, New Jersey, United States

Don Bailey, PhD

DISTINGUISHED FELLOW, RTI INTERNATIONAL

Modernizing Newborn Screening: High Patient Impact, Big Challenges

Research Triangle Park, North Carolina, United States

Bryan Baines

DIRECTOR, DUKE UNIVERSITY

Impactful Models and Resources for De-risking and Translating University-Held Innovations

Wake Forest, North Carolina, United States

Anthony Baldor, MBA;MS

VP, CORP STRAT & DEV, 4D MOLECULAR THERAPEUTICS

4D Molecular Therapeutics

Emeryville, California, United States

Michael Banyas, MPA

HEALTH SPECIALIST, NIHMD

Fostering Diversity and Bio-Equity Through Novel Financing and Training Initiatives in the Aging Innovation Ecosystem

Rockville, Maryland, United States

Szczepan Baran, MS, VMD

CHIEF SCIENTIFIC OFFICER, VERISIM LIFE

VeriSIM Life

Maria Barhams Sagoua

PRINCIPAL CONSULTANT, SAS INSTITUTE INC.

Advancing the landscape of drug repurposing: Diverse perspectives and solutions from the field

Gaithersburg, Maryland, United States

Marta Barrachina, MBA;PhD

CEO, ADMIT THERAPEUTICS S.L.

ADmit Therapeutics SL

ESPLUGUES DE LLOBREGAT, Spain

Annalisa Barrett

SENIOR ADVISOR, KPMG LLP

Best Practices for Building an Inclusive Biotech Company

San Diego, California, United States

Alison Bateman-House, MA;MPH;PhD

ASSISTANT PROFESSOR, NYU LANGONE MEDICAL CENTER

Individualized Therapeutics: Walking the Line Between Research and Treatment

New York, New York, United States

Hernan Bazan

CEO AND CO-FOUNDER OF SOUTH RAMPART PHARMA; PROFESSOR OF SURGERY, INNOVATION, OCHSNER HEALTH

South Rampart Pharma

South Rampart Pharma, LLC

New Orleans, Louisiana, United States

Edwin Beale

VICE PRESIDENT, BUSINESS DEVELOPMENT, IVEXSOL, INC.

Therapeutic Cell and Gene Therapy Introducing New Technologies to compress timelines, increase capacity and reduce risk

Lexington, Massachusetts, United States

Rasmus Bech Hansen

CEO, AIRFINITY

Stopping the Next Pandemic Before it Starts: What We’ve Learned

Loren Becker, MPP

ASSOCIATE PRINCIPAL, VACCINE POLICY AND MARKET ACCESS, AVALERE HEALTH

COVID-19 360°: Embedding Global Best Practices in Routine Regulatory Action and Preparing for the Next Pandemic

Washington, District of Columbia, United States

Jacob Becraft, PhD

CO-FOUNDER & CEO, STRAND THERAPEUTICS

Faster and Stronger: How RNA Will Advance Precision Medicine and Accessibility

Boston, Massachusetts, United States

Ken Beers

PARTNER, CLARIVATE

Buying into tomorrow’s drug platforms

Philadelphia, Pennsylvania, United States

Susan Begelman, MD

VICE PRESIDENT OF THE US RESPIRATORY AND INFLUENZA FRANCHISES , GENENTECH

The Future of Flu Protection: Novel Influenza Technologies

Jonathan Behr, PhD

PARTNER, DEMENTIA DISCOVERY FUND

Joining forces to accelerate innovation in neuroscience

Boston, Massachusetts, United States

Sue Behrens

RATHMANN PROFESSOR IN BIOPROCESSING AND DIRECTOR OF THE AMGEN BIOPROCESSING CENTER, KECK GRADUATE INSTITUTE

Getting It Right: How Early Engagements with CDMOs Add Value to Small Biotechs

Claremont, California, United States

Laurent Bekale

, STANFORD MEDICINE

Santa Maria Lab

Palo Alto, California, United States

Ann Beli?n, PhD

CEO, REJUVENATE BIO

Targeting Aging Pathways To Treat Chronic Disease

Heusden-Zolder, Belgium

Tim Belski

ACTING DIRECTOR FOR INDUSTRIAL BASE MANAGEMENT AND SUPPLY CHAIN, BARDA

US Government Investments in Pharmaceutical Manufacturing and Supply Chain for Today’s and Future Pandemics

Rich Bendis

FOUNDER, PRESIDENT AND CEO, BIO HEALTH INNOVATION

Building Bio Facilities and Bio Ecosystems: Federal, State and Private Resources

Rockville, Maryland,

Hamilton Bennett

ASSOCIATE DIRECTOR, VACCINE ACCESS AND PARTNERSHIPS, MODERNA THERAPEUTICS, INC

Getting to 100 Days: Driving Vaccine Innovation Between Pandemics

Cambridge, Massachusetts, United States

Sharon Benzeno, PhD, MBA

CHIEF COMMERCIAL OFFICER, IMMUNE MEDICINE, ADAPTIVE BIOTECHNOLOGIES

Early Scientific and Clinical Strategy for Optimizing Value Inflection in Oncology Financing and Dealmaking

Defining Correlates of Protection for COVID-19: The Technology is Here, The Time is Now

New York, New York,

Peter Berglund

CTO, HDT BIO

All Eyes on mRNA - Addressing Key Insights into the Next Blockbuster

Seattle, Washington, United States

Neil Berkley

CHIEF BUSINESS OFFICER, ABCELLERA BIOLOGICS

Maximizing the Potential of Platforms Through Creative and Effective Deal-Making Strategies

San Diego, California, United States

Stephanie Bewick

CHIEF BUSINESS OFFICER, DESTINY PHARMA PLC

Destiny Pharma plc

Brighton, United Kingdom

Laxminarayan Bhat, PhD

FOUNDER, PRESIDENT & CEO, REVIVA PHARMACEUTICALS, INC.

Reviva Pharmaceuticals Holdings Inc

Cupertino, California, United States

Sulagna Bhattacharya

CO-FOUNDER & CEO, NANOSCOPE THERAPEUTICS, INC.

Nanoscope Therapeutics

Bedford, Texas, United States

Shiva Bhowmik, PhD

COO, TRIO PHARMACEUTICALS, INC.

TRIO Pharmaceuticals, Inc.

San Carlos, California, United States

Oded Biran

CEO, NEURODEX, INC.

NeuroDex, Inc.

Natick, Massachusetts, United States

Kathie Bishop

SVP, RARE DISEASE, EXTERNAL INNOVATION & CHIEF SCIENTIFIC OFFICER, ACADIA PHARMACEUTICALS, INC

“Hope Lies in Dreams”—Ionis’s Stan Crooke and the First Drug for SMA Patients

San Diego, California, United States

Neena Bitritto-Garg, CFA

BIOTECH ANALYST, CITIGROUP

Neuropsychiatric Innovation and Fighting Stigma in Mental Health—Fireside Chat with Dr. Steve Paul, Karuna Therapeutics

New York, New York, United States

Angela Bitting

SVP, CORPORATE AFFAIRS, TWIST BIOSCIENCE

Biopharma Sustainability: Multilateral Guidance on Strategy, Opportunity, and Risk

South San Francisco, California, United States

Stacy Blain

CO-FOUNDER AND CSO, CONCARLO THERAPEUTICS

Concarlo Therapeutics

Brooklyn, New York, United States

Jay Blankenship, MBA;MD

SVP OF DEVELOPMENT, ZYLO THERAPEUTICS

Zylö Therapeutics

Greenville, South Carolina, United States

Katherine Bliss

, CSIS

Innovation and Access: What COVID-19 Therapeutics Can Teach Us About Preparing for the Next Pandemic

Leonard Blum, MBA

PRESIDENT & CHIEF EXECUTIVE OFFICER, XWPHARMA INCORPORATED

Showcase of Emerging Innovative Companies, Part 2

Redwood City, California, United States

Jeff Bockman, PhD

EVP, ONCOLOGY PRACTICE HEAD, CELLO HEALTH BIOCONSULTING

Early Scientific and Clinical Strategy for Optimizing Value Inflection in Oncology Financing and Dealmaking

Florham Park, New Jersey, United States

Travis Bond

CEO, ALTOIDA

Altoida

Tackling Post-Covid Cognitive Impairment

Washington, District of Columbia, United States

Natasha Bonhomme

CHIEF STRATEGY OFFICER, GENETIC ALLIANCE

Modernizing Newborn Screening: High Patient Impact, Big Challenges

Christopher Boone

VP, GLOBAL HEAD OF HEALTH ECONOMICS & OUTCOMES RESEARCH, ABBVIE

Enabling and Supporting Efficacy-Linked Pricing Contracts

North Chicago, Illinois,

Harm-Jan Borgeld

GLOBAL HEAD ASIA PARTNERING, ROCHE

Overcoming Complications in Cross-Border Licensing Deals with China

Shanghai, China

Fatima Bosch

PROF, UNIVERSITAT AUTONOMA BARCELONA

Gene Therapy Pioneers Discuss What's Next for Gene Therapy

Bellaterra, Spain

Alfred Botchway, PhD

CEO, ATTENTIVE SCIENCE, LLC

Moving Ideas Beyond The Lab

Stilwell, Kansas, United States

François BOUTIGNON, PhD

PRESIDENT & CEO, APTYS PHARMA

APTYS PHARMA

SAINT- BEAUZIRE, Auvergne-Rhone-Alpes, France

Robert Bowser, PhD

CHAIRMAN, NVECTOR

nVector, Inc.

Phoenix, Arizona, United States

Christopher Boyer, BS;MBA

CHIEF BUSINESS OFFICER, TESSARA THERAPEUTICS PTY LTD

Tessara Therapeutics Pty Ltd

Southbank, Victoria, Australia

Hannah Bracken

POLICY ANALYST, US DEPARTMENT OF COMMERCE/INTERNATIONAL TRADE ADMINISTRATION

Is this the End of Global Clinical Trials? How to Navigate Data Privacy and National Security Restrictions Affecting Cross-Border Data Transfers in the EU and China

Washington, District of Columbia, United States

Charlotte Bradshaw

CEO & FOUNDER, EVRIMA TECHNOLOGIES PTY LTD

Evrima Technologies Pty Ltd

Sydney, New South Wales, Australia

Steven Braithwaite

CHIEF EXECUTIVE OFFICER, ALKAHEST, INC.

Targeting Aging Pathways To Treat Chronic Disease

San Carlos, California, United States

Florian Brand

CO-FOUNDER, CEO, ATAI LIFE SCIENCES

atai Life Sciences

Berlin, Germany

Alexander Breidenbach, MBA;PhD

CHIEF BUSINESS OFFICER, ACM BIOSCIENCES AG

ACM Biolabs Pte LTD

Basel, Basel-Stadt, Switzerland

Isaac Bright, MD

CEO, RUBRYC THERAPEUTICS, INC.

RubrYc Therapeutics, Inc.

San Carlos, California, United States

Marisa Briones

CO-FOUNDER/CEO, BDH PHARMA, LLC

BDH Pharma, LLC

Valley Village, California, United States

Max Bronstein

ASSISTANT DIRECTOR FOR HEALTH INNOVATION, OFFICE OF SCIENCE AND TECHNOLOGY POLICY

Modernizing Newborn Screening: High Patient Impact, Big Challenges

Caitlin Brown, PhD

HEAD OF BUSINESS DEVELOPMENT, PEPPER BIO

Pepper Bio

Dedham, Massachusetts, United States

Meredith Brown Tuttle

VICE PRESIDENT, REGULATORY, RECURSION PHARMACEUTICALS, INC.

Where Do We Go from Here? Optimizing America’s Health Care Strategy for Advancing Responsible AI

Santa Clara, California, United States

Leigh Ann Bruhn

EVP, SYNEOS HEALTH

Can Patient Perspectives Break Through Value Assessments That Rely on the QALY?

Overcoming non-price barriers to patient access

New York, New York, United States

Darren Buchwald

SVP, VACCINES AND PHARMACEUTICAL PRODUCTS, AMYRIS, INC.

Amyris

Emeryville, California, United States

Matt Buckley, PhD

COFOUNDER, RETRO BIOSCIENCES

Targeting Aging Pathways To Treat Chronic Disease

Redwood City, California, United States

Karim Budhwani, PhD

CEO, CERFLUX, INC.

Cancer Trials Don’t Have To Fail 90% of the Time. Seriously.

Birmingham, Alabama, United States

Alex Burgin

SR DIRECTOR, THE BROAD INSTITUTE

Feeding the Pipeline

Cambridge, Massachusetts, United States

Quinton Burns

JUNIOR BIOGENEIUS FINALIST

Future of Biotech

Christopher Burns, PhD

PRESIDENT AND CEO, VENATORX PHARMACEUTICALS, INC.

Venatorx Pharmaceuticals

Malvern, Pennsylvania, United States

Clara Burtenshaw

PARTNER AND INVESTOR , NEO KUMA VENTURES

Psychedelics: What Will It Take To Get Them to Market?

London,

Amy Butler

PRESIDENT, BIOSCIENCES DIVISION, THERMO FISHER SCIENTIFIC, INC

How Do We Make Cell Therapy Sustainable Long Term?

Carlsbad, California, United States

George Cagna

CEO, KIFFIK BIOMEDICAL

Kiffik Biomedical Inc.

Providence, Rhode Island, United States

Cynthia Cai

VENTURE PARTNER, VIVA BIOINNOVATOR

To Invest or Not to Invest, Cross-Border Investments in the Age of Rising Global Uncertainties

Newark, Delaware, United States

Stacie Calad-Thomson

CHIEF STRATEGY OFFICER AND HEAD OF DRUG DISCOVERY, BIOSYMETRICS

BioSymetrics

Huntington, New York, United States

Robert Califf

COMMISSIONER, FDA

Fireside Chat with the Commissioner of Food and Drugs, Dr. Robert M. Califf

Riccardo Canevari

CEO, RADIOPHARM THERANOSTICS

Radiopharm Theranostics

Carlton, Western Australia, Australia

Ping Cao

VP BUSINESS DEVELOPMENT, HENLIUS BIOTECH

Shanghai Henlius Biotech, Inc.

Milpitas, California, United States

James Cappuccio

MANAGING DIRECTOR, H.C. WAINWRIGHT & COMPANY

Utilizing an Existing SPAC To Take Your Private Biotech Company Public

New York, New York,

Dana Caron

DIRECTOR OF MARKETING EXECUTION, UPS

Supply chain crisis: forward looking solutions

Atlanta, Georgia, United States

Pierre Catignol

HEAD OF MANUFACTURING, SAMSUNG BIOLOGICS

All Eyes on mRNA - Addressing Key Insights into the Next Blockbuster

Incheon, Korea, Republic of

Lauren Cautilli

MANAGER, SBD EXTERNAL EVENT OPERATIONS, BRISTOL MYERS SQUIBB

Bristol Myers Squibb

Langhorne, Pennsylvania, United States

Patrizia Cavazzoni

DEPUTY DIRECTOR FOR OPERATIONS, CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), THE U.S. FOOD AND DRUG ADMINISTRATION

FDA Town Hall

Silver Spring, Maryland, United States

Olivia Cavlan, MD

CHIEF CORPORATE DEVELOPMENT & STRATEGY OFFICER, ALCHEMAB

Alchemab Therapeutics

Kings Cross, United Kingdom

James Cavuoto

EDITOR, NEUROTECH REPORTS

Alzheimer’s: Tackling Scientific and Systemic Challenges to Change the Future of Alzheimer’s Care

San Francisco, California, United States

Andrew Chang

VICE PRESIDENT, QUALITY AND REGULATORY COMPLIANCE, QI&I, NOV, NOVO NORDISK

Development of Points to Consider: Comparability Considerations for Advanced Therapy Medicinal Products Subject to Changes in their Manufacturing Process

Washington DC, District of Columbia, United States

Hemmie Chang

PARTNER & CO-CHAIR, LIFE SCIENCES GROUP; CHAIR, LICENSING & STRATEGIC ALLIANCES PRACTICE, FOLEY HOAG LLP

Navigating Asia-Pacific Innovation Deal Opportunities

Boston, Massachusetts, United States

David Chang, PhD

CHIEF EXECUTIVE OFFICER, WUXI ATU, WUXI APPTEC

Recombinant protein manufacturing: Lessons to be taken from the emerging cell and gene therapy space

Therapeutic Cell and Gene Therapy Introducing New Technologies to compress timelines, increase capacity and reduce risk

Philadelphia, Pennsylvania, United States

John Chant, PhD

CEO, FILTRICINE, INC

Filtricine, Inc.

Santa Clara, California, United States

Rick Chapman

CHIEF SCIENCE OFFICER, IVI

Can Patient Perspectives Break Through Value Assessments That Rely on the QALY?

Alexandria, Virginia, United States

Vikram Chaudhery, PhD

PARTNER, GENOA VC

The New Journey of a Data Point: Digital Innovation for a Powerful Purpose

San Francisco, California, United States

Po Chen

CEO, CANCERFREE BIOTECH LTD.

CancerFree Biotech Ltd.

Taipei City, Taiwan

Benjamin Chen

PARTNER, PANACEA HEALTHCARE VENTURE

To Invest or Not to Invest, Cross-Border Investments in the Age of Rising Global Uncertainties

Janice Chen, PhD

CO-FOUNDER & CTO, MAMMOTH BIOSCIENCES

Evolution of An Industry: Forming Biotech Enterprises, Past, Present…and Future

Binbin Chen

CEO, VCREATE, INC.

Vcreate

Menlo Park, California, United States

Mo Chen, MBA;PhD

CHIEF EXECUTIVE OFFICER, WNT SCIENTIFIC LLC

Wnt Scientific LLC

New York, New York, United States

Shawn Cho, MBA;RPh

DIRECTOR OF BUSINESS DEVELOPMENT, LISCURE BIOSCIENCES

LISCure Biosciences Inc.

Gyeonggi-do, Korea, Republic of

Michael Choi

CHIEF BUSINESS OFFICER, CSTONE PHARMACEUTICALS

Navigating Asia-Pacific Innovation Deal Opportunities

Shanghai, Shanghai, China

Will Chou

CEO, ARUVANT SCIENCES, INC.

Aruvant Sciences

Millburn, New Jersey, United States

Judy Chou, PhD

CEO AND PRESIDENT, ALTRUBIO, INC.

AltruBio Inc.

San Francisco, California, United States

Robert Chu

CEO, EMBLEEMA

Embleema

Metuchen, New Jersey, United States

Eddie Chung

CEO, COASTAR THERAPEUTICS, INC.

Coastar Therapeutics Inc.

San Diego, California, United States

Jordan Clark

CCO, DIACEUTICS

Challenges in Implementing Personalized Medicine in Clinical Practice

Belfast, United Kingdom

Matthew Clark

BOARD MEMBER AND ADVISOR, CERFLUX, INC.

Cancer Trials Don’t Have To Fail 90% of the Time. Seriously.

Gaithersburg, Maryland, United States

Farley Cleghorn, MD, MPH

CHIEF MEDICAL OFFICER AND GLOBAL HEAD, HEALTH PRACTICE, PALLADIUM

Defining Correlates of Protection for COVID-19: The Technology is Here, The Time is Now

Brandon Clough, MBA

CHIEF REVENUE OFFICER, PSC BIOTECH CORPORATION

PSC

Pomona, California, United States

Carole Cobb

CHIEF OPERATING OFFICER, GREENLIGHT BIOSCIENCES

All Eyes on mRNA - Addressing Key Insights into the Next Blockbuster

Medford, Massachusetts, United States

Lindsay Cobbs

US POLICY & STRATEGY HEAD, BEIGENE, LTD.

Diversity and Inclusion in Clinical Trials: Concrete Strategies for Enhancing Health Equity

Cambridge, Massachusetts, United States

Stanley Cohen

, STANFORD UNIVERSITY

Evolution of An Industry: Forming Biotech Enterprises, Past, Present…and Future

Stanford, California, United States

David Cole, PhD

PRESIDENT AND CEO, SCIENCE HISTORY INSTITUTE

Evolution of An Industry: Forming Biotech Enterprises, Past, Present…and Future

Philadelphia, Pennsylvania, United States

Ben Comer

CHIEF EDITOR, LIFE SCIENCE LEADER MAGAZINE

Cultivating innovation post acquisition: Bayer and Vividion’s arm’s length model

John Concato, MD

ASSOCIATE DIRECTOR FOR REAL-WORLD EVIDENCE ANALYTICS, OFFICE OF MEDICAL POLICY, CDER, FDA SILVER SPRING, MARYLAND, UNITED STATES , FDA

Is Real-world evidence used optimally in regulatory decision-making?

Chad Conner

CEO, MYCRODOSE THERAPEUTICS

Mycrodose Therapeutics

San Diego, California, United States

Crissa Cook, BA;JD

PARTNER | PATENT ATTORNEY, HOVEY WILLIAMS LLP

Moving Ideas Beyond The Lab

Overland Park, Kansas, United States

Jacqueline Corrigan Curay

PRINCIPAL DEPUTY CENTER DIRECTOR , FDA

Diversity and Inclusion in Clinical Trials: Concrete Strategies for Enhancing Health Equity

Daniel Couto

CHIEF OPERATING OFFICER, VEDANTA BIOSCIENCES INC

Gut Check: Current Trends in Microbiome Therapeutics Development

Cambridge, Massachusetts, United States

David Cox

, THE TELEGRAPH

Tackling Post-Covid Cognitive Impairment

Psychedelics: What Will It Take To Get Them to Market?

John Craighead, PhD

CHIEF FINANCIAL OFFICER, ELPISCIENCE BIOPHARMACEUTICALS

Overcoming Complications in Cross-Border Licensing Deals with China

Pudong, Shanghai, China

David Crean

MANAGING PARTNER, CARDIFF ADVISORY LLC

Persuasive Pitching – Do You Have the Talent to Engage Investors?

Cardiff By The Sea, California, United States

Imran Cronk

CEO AND FOUNDER, RIDE HEALTH

Overcoming non-price barriers to patient access

New York, New York, United States

Stanley Crooke, MD;PhD

CEO AND CHAIRMAN OF THE BOARD, N-LOREM FOUNDATION

“Hope Lies in Dreams”—Ionis’s Stan Crooke and the First Drug for SMA Patients

Carlsbad, California, United States

Kevin Curran

SCIENTIFIC ADVISOR, INSTRUCTOR, BIOTECH PRIMER

Introduction to Gene Therapy

Towson, Maryland, United States

Pam Cusick

SENIOR VICE PRESIDENT, RARE PATIENT VOICE

Participant Sensitivity: Amplifying the Voice of the Patient in Clinical Trials

Towson, Maryland, United States

Amy Cusick

SENIOR PROPERTY & CASUALTY RISK, RISK ENGINEERING SERVICES, CHUBB

Limiting what could be Limitless: Minimizing risk through effective business contingency planning

Whitehouse Station, New Jersey, United States

Kenneth Custer, PhD

VICE PRESIDENT, BUSINESS DEVELOPMENT AND LILLY NEW VENTURES, ELI LILLY AND COMPANY

Maximizing the Potential of Platforms Through Creative and Effective Deal-Making Strategies

Eli Lilly and Company

Indianapolis, Indiana, United States

Jie Liu D'Elia, PhD

SRVP, ONCOLOGY, HEMATOLOGY, CELL THERAPY MEDICINE, BRISTOL MYERS SQUIBB

Wisdom and Wagers: Perspectives from Big Pharma Dealmakers

Trenton, New Jersey, United States

Igor DaCruz

MANAGING DIRECTOR, RUNWAY GROWTH CAPITAL

Options for Raising Capital in a Down Market

San Diego, California, United States

Hiroki Danno

CEO, KNOWLEDGE PALETTE

Knowledge Palette, Inc.

Kanagawa, Japan

BRIAN DARMODY

CHIEF STRATEGY OFFICER, ASSOCIATION OF UNIVERSITY RESEARCH PARKS

Building Bio Facilities and Bio Ecosystems: Federal, State and Private Resources

College Park, Maryland, United States

Nataraj Dasgupta

VICE PRESIDENT, ADVANCED ANALYTICS, RXDATASCIENCE INC., A DIVISION OF SYNEOS HEALTH

How Digital Health Technical Innovation is Driving Decentralized Clinical Trial Success

Apex, North Carolina, United States

Allen Davidoff, PhD

CEO AND PRESIDENT, XORTX THERAPEUTICS

XORTX Therapeutics Inc.

Calgary, Alberta, Canada

Michael Davies, MBBS;MD

CEO & FOUNDER, CAROCELL BIO

Carocell Bio

Durham, North Carolina, United States

Melika Davis

SENIOR VICE PRESIDENT, GLOBAL CLINICAL OPERATIONS, BEIGENE, USA, INC.

Diversity and Inclusion in Clinical Trials: Concrete Strategies for Enhancing Health Equity

San Mateo, California, United States

Marianne De Backer, MBA;MSc;PhD

EVP, HEAD OF BUSINESS DEVELOPMENT AND LICENSING, BAYER PHARMACEUTICALS

Cultivating innovation post acquisition: Bayer and Vividion’s arm’s length model

Funding Transformational Platforms: Sustaining Development of Next Generation Medicines in a Challenging Market

Interview with Marianne De Backer

Berlin, Germany

Sandra de Castro Barros

SECRETARY, MINISTRY OF HEALTH - BRAZIL

Innovation and Access: What COVID-19 Therapeutics Can Teach Us About Preparing for the Next Pandemic

Brasília, Distrito Federal, Brazil

Alban De La Sabliere

GLOBAL HEAD OF PARTNERING, SANOFI

Sanofi

Deal-Making in the Current Environment: A Fireside Chat with Alban de La Sablière, Head of Partnering, Sanofi

Paris, France

Andrea de Souza

AVP, ELI LILLY AND COMPANY

Why the FDA Will Bet More on in Silico Simulations To Trigger Better Success Rates for NDAs

Allison DeAngelis

SENIOR HEALTHCARE REPORTER, STAT

CNS Drug Development: Do Biomarkers Hold the Future for Patients?

Faster and Stronger: How RNA Will Advance Precision Medicine and Accessibility

Boston, Massachusetts,

Anthony DeBoer

VP ,BUSINESS DEVELOPMENT, SYNAFFIX BV

Synaffix BV

Oss, Netherlands

Kristen DeBord, PhD

ACTING DEPUTY DIRECTOR, OFFICE OF STRATEGY, POLICY, PLANNING, AND REQUIREMENTS, HHS

US Government Investments in Pharmaceutical Manufacturing and Supply Chain for Today’s and Future Pandemics

The Future of Flu Protection: Novel Influenza Technologies

Bryan Dechairo, PhD

PRESIDENT & CEO, SHERLOCK BIOSCIENCES

Sherlock Biosciences

Watertown, Massachusetts, United States

R. Angelo Declaro

ASSOCIATE DIRECTOR (ACTING) FOR GLOBAL CLINICAL SCIENCES , US FDA ONCOLOGY CENTER OF EXCELLENCE (OCE)

International Regulatory Strategy: Impact of ORBIS

District Of Columbia,

Willyanne DeCormier Plosky, DrPH

PROGRAM MANAGER, MRCT CENTER OF HARVARD AND BWH

Diversity and Inclusion in Clinical Trials: Concrete Strategies for Enhancing Health Equity

Equity by Design: Utility of a Metrics Framework and Metrics To Evaluate Progress on Diversity, Equity, and Inclusion in Clinical Research

Cambridge, Massachusetts, United States

Thomas Defay

DEPUTY HEAD OF DIAGNOSTICS STRATEGY AND DEVELOPMENT, ALEXION PHARMACEUTICALS, INC

Advancing Policies to Shorten the Rare Disease Patient’s Diagnostic Journey

Artificial Intelligence and Machine Learning: Case Studies in Rare Disease Drug Development

Boston, Massachusetts, United States

Kathryn DeFea, PhD

CEO, PARMEDICS

PARMedics

Temecula, California, United States

Laura Deming

Tuesday Keynote: BIO Unbound - Conversations Featuring Laura Deming, Dr. Kafui Dzirasa, Dr. Michelle McMurry-Heath, Dr. Alaa Murabit, and Dr. Siddhartha Mukherjee

Jennifer Dent

PRESIDENT, BIO VENTURES FOR GLOBAL HEALTH

Achieving Global Health Equity with BioPharma and Medtech

Seattle, Washington, United States

Mark DePristo, PhD

CEO AND CO-FOUNDER, BIGHAT BIOSCIENCES

Monetizing AI & Machine Learning Applications in Life Sciences

Los Altos, California,

Lopa Desai

OWNER, ARENA PHARMACEUTICALS, INC.

Out-License, Co-Promote, or Solo-First launch? Insights From an Expert Panel and a Decade of U.S. and EU First-Launch and Partnering Data

Camarillo, California, United States

Madhu Deshmukh

VICE PRESIDENT OF PROGRAM STRATEGIES & IMPACT, CARE INTERNATIONAL

Where Health Meets Policy: Addressing Gender Equity through Health

Atlanta, Georgia, United States

Chat DeSilva

DIRECTOR, BUSINESS DEVELOPMENT, BIOCENTRIQ

BioCentriq

Newark, New Jersey, United States

Scott DeWire

HEAD OF US BUS. DEV. & LICENSING, BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.

Boehringer Ingelheim Pharmaceuticals, Inc.

Ridgefield, Connecticut, United States

Drew Diamond

ASSOCIATE GENERAL COUNSEL/EXECUTIVE DIRECTOR , INTELLECTUAL PROPERTY & LITIGATION

Legal Considerations for Biosimilars that Business People Need to Know

Nick Diamond

DIRECTOR, CROWELL & MORING INTERNATIONAL

Vaccine Innovation and the Future of Life-Course Immunization

Washington, District of Columbia, United States

Dolores Diaz

SCIENCES VICE PRESIDENT, DEVELOPMENT, DENALI THERAPEUTICS

CNS Drug Development: Do Biomarkers Hold the Future for Patients?

Palo Alto, California, United States

Robert DiFazio, PhD

CEO, PARALLEL BIO

Parallel Bio

Los Angeles, California, United States

Yuanhua Ding, PhD

CEO, ALLIANTHERA BIOPHARMA

To Invest or Not to Invest, Cross-Border Investments in the Age of Rising Global Uncertainties

Natick, Massachusetts, United States

David Dodd

CHAIRMAN, CEO, GEOVAX LABS, INC

GeoVax Labs, Inc.

Smyrna, Georgia, United States

Marty Driscoll

CEO, ONCONANO MEDICINE, INC.

OncoNano Medicine, Inc.

Southlake, Texas, United States

Quardricos Driskell

VICE PRESIDENT OF PUBLIC POLICY & GOVERNMENT AFFAIRS, AUTOIMMUNE ASSOCIATION

Calculating the Value and Impact of Accelerated Approvals

Clinton Township, Michigan, United States

Eric Dube, PhD

PRESIDENT & CEO, TRAVERE THERAPEUTICS, INC.

Best Practices for Building an Inclusive Biotech Company

Fireside Chat: The Accelerated Approval Pathway and the Importance to Patients

San Diego, California, United States

Michael Dudley

CEO, TRANSCODE THERAPEUTICS

TransCode Therapeutics, Inc.

Boston, Massachusetts, United States

Michael Dudley, PharmD

PRESIDENT & CEO, THE MEDICINES COMPANY SAN DIEGO LLC - C/O QPEX BIOPHARMA

The Silent Pandemic: Tackling Antimicrobial Drug Resistance (AMR)

San Diego, California, United States

Denis Dufrane

CEO, NOVADIP BIOSCIENCES

Novadip Biosciences

Mont-Saint-Guibert (Corbais ), Belgium

Kristi Dula

DIRECTOR, OFFICE OF ENTREPRENEURSHIP INNOVATION & TECHNOLOGY, ILLINOIS DEPARTMENT OF COMMERCE & ECONOMIC OPPORTUNITY

Building a Strong Biomanufacturing Workforce in the United States: A Conversation with State Economic Development Experts

Frida Dunger Johnsson

EXECUTIVE DIRECTOR, IFPA

Global Patient Advocacy – Addressing Health Inequity Across the Globe

Stockholm, Sweden

Melissa Dupont

R&D PATIENT ENGAGEMENT LEAD, SANOFI

Partnering for Progress: Collaborating With Patient Organizations To Advance Therapy Development and Maximize Patient Benefit

Bridgewater, New Jersey, United States

Carolyn Durham, PhD

CHIEF SCIENTIFIC OFFICER, RENOVION

Renovion, Inc.

Chapel Hill, North Carolina, United States

Priyanka Dutta Passecker, MBA;PhD

CEO AND CO-FOUNDER, HEALIVA SA

Healiva SA

Lugano, Switzerland

John Dwyer

PRESIDENT, GLOBAL ALZHEIMER'S PLATFORM FOUNDATION

Calculating the Value and Impact of Accelerated Approvals

Washington, District Of Columbia, United States

Kafui Dzirasa

K. RANGA RAMA KRISHNAN ASSOCIATE PROFESSOR, DUKE UNIVERSITY MEDICAL CENTER

Tuesday Keynote: BIO Unbound - Conversations Featuring Laura Deming, Dr. Kafui Dzirasa, Dr. Michelle McMurry-Heath, Dr. Alaa Murabit, and Dr. Siddhartha Mukherjee

David Earnshaw

ASSOCIATE VICE PRESIDENT, MERCK

The big bang in pharma legislation: The European epicenter shaping global healthcare and a competitive industry

Kenilworth, New Jersey, United States

Julie Eastland

PRESIDENT AND CHIEF EXECUTIVE OFFICER, HARPOON THERAPEUTICS

How to Survive a Stormy Biotech Season: Thriving in a Challenging Market

South San Francisco, California, United States

Celia Economides

EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER, GRITSTONE BIO

Options for Raising Capital in a Down Market

Nevan Elam

CEO/FOUNDER, REZOLUTE

Ending The Cycle of Chronic Disease: Leveraging New Therapeutic Approaches with Disease-Modifying Potential

Redwood City, California, United States

Mark Emalfarb

CHIEF EXECUTIVE OFFICER, DYADIC INTERNATIONAL, INC

Dyadic International, Inc.

Jupiter, Florida, United States

Victoria Emerick, PhD

EXECUTIVE DIRECTOR & GLOBAL HEAD, SUSTAINABILITY STRATEGY, BRISTOL MYERS SQUIBB

Biopharma Sustainability: Multilateral Guidance on Strategy, Opportunity, and Risk

Princeton, New Jersey, United States

Sebastien Enault

CHIEF BUSINESS OFFICER, MEDINCELL SA

MedinCell

Jacou, Occitania, France

Rafael Escandon, DrPH;MPH;PhD

PRINCIPAL, DGBI CONSULTING

Individualized Therapeutics: Walking the Line Between Research and Treatment

Bainbridge Island, Washington, United States

Philippe Etienne

FRENCH AMBASSADOR IN THE US, FRENCH EMBASSY IN THE US

Spurring Biotech Innovation Across The Globe: A High-Level Discussion

Washington, District of Columbia, United States

Amit Etkin, MD;PhD

CEO, ALTO NEUROSCIENCE INC

CNS Drug Development: Do Biomarkers Hold the Future for Patients?

Los Altos, California, United States

Jeanette Evans

VP BUSINESS DEVELOPMENT, ADAPTIMMUNE

Out-License, Co-Promote, or Solo-First launch? Insights From an Expert Panel and a Decade of U.S. and EU First-Launch and Partnering Data

Oxford, United Kingdom

Jay Evans, PhD

PRESIDENT & CEO, INIMMUNE CORPORATION

Inimmune Corporation

Missoula, Montana, United States

Stacy Feld, JD

HEAD, JOHNSON & JOHNSON INNOVATION, WEST NORTH AMERICA, AUSTRALIA & NEW ZEALAND, JOHNSON & JOHNSON

Johnson & Johnson Innovation

Impactful Models and Resources for De-risking and Translating University-Held Innovations

South San Francisco, California, United States

Agustin Fernadez III

CEO, RATIONAL VACCINES

Rational Vaccines, Inc.

Woburn, Massachusetts, United States

Kathy Fernando

VICE PRESIDENT AND HEAD OF WORLDWIDE RESEARCH, DEVELOPMENT AND MEDICAL OPERATIONS AND HEAD OF MRNA SCIENTIFIC PLANNING AND OPERATIONS, PFIZER INC.

Delivering on the next mRNA-based breakthroughs

New York, New York, United States

Daniel Fernando Filmus

MINISTER OF SCIENCE, TECHNOLOGY AND INNOVATION

Argentina

Brian Finrow

CO-FOUNDER & CEO, LUMEN BIOSCIENCE

Recombinant protein manufacturing: Lessons to be taken from the emerging cell and gene therapy space

Lumen Bioscience

Seattle, Washington,

Wainwright Fishburn

GLOBAL CHAIR, DIGITAL HEALTH, COOLEY

Partnering Strategies for Success in Digital Health

San Diego, California,

Nasha Fitter

COFOUNDER AND CEO, FOXG1 RESEARCH FOUNDATION

Female Founders: Paving the Way for Innovation and Equity

New York, New York, United States

Daniel Folk

ASSISTANT DIRECTOR OF CAREER SERVICES, BIOKANSAS

How Academia, Industry, Government, & Nonprofit Organizations Advance Science

Moving Ideas Beyond The Lab

Shawnee Mission, Kansas, United States

David Fontana, PhD

CHIEF BUSINESS AND STRATEGY OFFICER, UMOJA BIOPHARMA

Funding Transformational Platforms: Sustaining Development of Next Generation Medicines in a Challenging Market

Seattle, Washington, United States

Bijean Ford, PhD

MEDICAL WRITER, BIOTECHNOLOGY INSTITUTE

Future of Biotech

Stone mountain, Georgia, United States

Kristen Fortney, PhD

CEO, BIOAGE LABS

Targeting Aging Pathways To Treat Chronic Disease

Richmond, California, United States

Sarah Fortt

PARTNER, LATHAM & WATKINS, LLP

Harnessing the Power of Biotechnology on ESG Issues

Austin, Texas, United States

David Foster, JD;PhD

CEO, ISLAND PHARMACEUTICALS

Island Pharmaceuticals, Ltd

Camberwell, Victoria, Australia

Adam Fowler, M.S., MSc

SVP, TECHNICAL OPERATIONS, LOCANABIO, INC.

Therapeutic Cell and Gene Therapy Modalities - Business and Manufacturing Strategies Impacting the Decision to Develop One Therapy Type vs. Another

San Diego, California, United States

Kathy Francissen

HEAD OF REGULATORY, PT CELL & GENE THERAPEUTICS, GENENTECH, A MEMBER OF THE ROCHE GROUP

Development of Points to Consider: Comparability Considerations for Advanced Therapy Medicinal Products Subject to Changes in their Manufacturing Process

South San Francisco, California, United States

Cedric Francois, MD;PhD

CO-FOUNDER & CEO/PRESIDENT, APELLIS PHARMACEUTICALS, INC

How to Survive a Stormy Biotech Season: Thriving in a Challenging Market

Waltham, Massachusetts, United States

Craig Fraser

CHIEF EXECUTIVE OFFICER & PRESIDENT, WINDTREE THERAPEUTICS, INC.

Windtree Therapeutics, Inc.

Warrington, Pennsylvania, United States

Trivia Frazier, MBA;PhD

CEO, OBATALA SCIENCES

Fostering Diversity and Bio-Equity Through Novel Financing and Training Initiatives in the Aging Innovation Ecosystem

New Orleans, Louisiana, United States

Cathy Friedman

EXECUTIVE VENTURE PARTNER, GOOGLE VENTURES

Primed for Growth: Innovating to Address the Business Opportunity to Build a Women’s Health Market

Cambridge, Massachusetts, United States

Gregory Frost, PhD

CEO, EXUMA BIOTECH CORP.

Overcoming Complications in Cross-Border Licensing Deals with China

West Palm Beach, Florida, United States

Ryan Fukushima, MBA

COO, TEMPUS

FDA's RWE Grantees: One Year On

Chicago, Illinois, United States

David Gailani

PROFESSOR OF PATHOLOGY AND MEDICINE, VANDERBILT UNIVERSITY

Exploring Factor XI: A Paradigm Shift as a Hemostasis Sparing Anticoagulant

Erick Gamelin, MD;PhD

CEO/CSO, ONCOXOME, INC.

OncoXome, Inc.

Newbury Park, California, United States

Matthew Gantz

PRESIDENT AND CEO, CASTLE CREEK BIOSCIENCES

Castle Creek Biosciences, Inc.

Exton, Pennsylvania, United States

Robert Garber

PARTNER, 7WIREVENTURES

Investors' Perspectives - Digital Health Trends and Investment Thesis in 2022 and Beyond

Chicago, Illinois, United States

Jorge Garces

CSO, EXACT SCIENCES CORPORATION

The Future for Liquid Biopsy and Cancer Detection

La Jolla, California, United States

Pat Garcia-Gonzalez, MPH

CEO, THE MAX FOUNDATION

Changing the Paradigm: Expanding Access to Oncology Medicines

Seattle, Washington, United States

EAMONN GARDNER

PARTNER, COOLEY LLP

Legal Considerations for Biosimilars that Business People Need to Know

Denver, Colorado, United States

Stephen Gardner

CEO, PRECISIONLIFE

Psychedelics: What Will It Take To Get Them to Market?

Oxford, United Kingdom

Robert Garmise, PharmD;PhD

ASSOCIATE DIRECTOR, BRISTOL MYERS SQUIBB

Space & Microgravity as an Innovation Platform for R&D

New Brunswick, New Jersey, United States

Vrushali Gaud

MANAGING DIRECTOR, ACCENTURE, LLP

Harnessing the Power of Biotechnology on ESG Issues

New York, New York, United States

Josette Gbemudu

EXECUTIVE DIRECTOR, HEALTH EQUITY, MERCK

Achieving Global Health Equity with BioPharma and Medtech

Jackson, New Jersey, United States

Dan Gebremedhin, BS, MBA, MD

PARTNER, FLARE CAPITAL

Investors' Perspectives - Digital Health Trends and Investment Thesis in 2022 and Beyond

San Diego, California,

Nicholas Geisse

CHIEF SCIENCE OFFICER, CURI BIO

Curi Bio

Seattle, Washington,

James Geraghty

CHAIRMAN, BVGH GUESTS

Fireside Chat: A Discussion on the Orphan Drug Revolution

Boston, Massachusetts, United States

Fabian Gerlinghaus

CEO, CELLARES CORPORATION

How Do We Make Cell Therapy Sustainable Long Term?

South San Francisco, California, United States

Geno Germano

PRESIDENT & CHIEF EXECUTIVE OFFICER, ELUCIDA ONCOLOGY, INC

Elucida Oncology

Monmouth Junction, New Jersey, United States

Brad Gescheider, MBA

GLOBAL HEAD-DIGITAL INNOVATION AND PATIENT SERVICES, IMMUNOLOGY, SANOFI

Partnering Strategies for Success in Digital Health

Mathieu Ghadanfar

BUSINESS DEVELOPMENT & LICENCING OFFICER, ZIPHIUS VACCINES

Ziphius Vaccines

Merelbeke, Belgium

Yong Song Gho

CEO, ROSETTA EXOSOME CO., LTD.

Rosetta Exosome Co., Ltd.

Seongnam, Korea, Republic of

Anirvan Ghosh, PhD

CEO, UNITY

Ending The Cycle of Chronic Disease: Leveraging New Therapeutic Approaches with Disease-Modifying Potential

Albert Gianchetti, MBA

PRESIDENT & CEO, XYLOCOR THERAPEUTICS

XyloCor Therapeutics

Wayne, Pennsylvania, United States

John Gill

SPECIAL AGENT, DEPARTMENT OF JUSTICE

Protecting Your Global Assets

San Diego, California, United States

Jeff Gilmore

CHIEF EXECUTIVE OFFICER, CGMPNOW

cGMPnow

Boulder, Colorado, United States

Jacob Glanville, PhD

FOUNDER/CEO/PRESIDENT, CENTIVAX, INC.

Centivax Inc

South San Francisco, California, United States

John Glasspool

CHIEF EXECUTIVE OFFICER, ANTHOS THERAPEUTICS

Exploring Factor XI: A Paradigm Shift as a Hemostasis Sparing Anticoagulant

Cambridge, Massachusetts, United States

Joseph Gleeson, MD

RADY PROFESSOR OF NEUROSCIENCES , UCSD

Individualized Therapeutics: Walking the Line Between Research and Treatment

Clive Glover, PhD

GENERAL MANAGER, GENE THERAPY, PALL BIOTECH

Opportunity for All: Innovations Realizing on the Promise of Genomic Medicine

Accelerating the Industrialization of Genomic Medicine

Portsmouth, United Kingdom

Dana Goldman

DEAN AND C. ERWIN AND IONE L. PIPER CHAIR, SOL PRICE SCHOOL OF PUBLIC POLICY, UNIVERSITY OF SOUTHERN CALIFORNIA

Enabling and Supporting Efficacy-Linked Pricing Contracts

Los Angeles, California,

Linda Goler Blount, MPH

PRESIDENT AND CHIEF EXECUTIVE OFFICER, BLACK WOMEN'S HEALTH IMPERATIVE

Fireside Chat: The Accelerated Approval Pathway and the Importance to Patients

Atlanta, Georgia, United States

Andrew Gomperts, JD;MBA

PRESIDENT AND CEO, HILLHURST BIOPHARMACEUTICALS, INC.

Hillhurst Biopharma

San Diego, California, United States

Cecilia Gonzalo

PARTNER, OBERLAND CAPITAL MANAGEMENT

Options for Raising Capital in a Down Market

New York, New York, United States

Jennifer Good, CPA

PRESIDENT & CEO, TREVI THERAPEUTICS

Trevi Therapeutics, Inc

New Haven, Connecticut, United States

Neil Gordon

MANAGING DIRECTOR, BPTG

Recombinant protein manufacturing: Lessons to be taken from the emerging cell and gene therapy space

Adrian Gottschalk

CHIEF EXECUTIVE OFFICER & PRESIDENT, FOGHORN THERAPEUTICS

From Scientific Breakthrough to Patient Impact: Bringing the Promise of Protein Degrader Therapies to Reality

Cambridge, Massachusetts, United States

Phil Gotwals

GLOBAL HEAD, NIBR BD&L, NOVARTIS

Novartis

Cambridge, Massachusetts, United States

Kiri Granger

DR, MONUMENT THERAPEUTICS

Tackling Post-Covid Cognitive Impairment

Cheshire, United Kingdom

Scott Gray

CEO, CLINCIERGE

Participant Sensitivity: Amplifying the Voice of the Patient in Clinical Trials

Philadelphia, Pennsylvania, United States

Dave Greenwald, PhD

VP, BUSINESS DEVELOPMENT, DEERFIELD MANAGEMENT COMPANY LP

Feeding the Pipeline

New York, New York, United States

Megan Grether, PhD

BD & L, BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH

Boehringer Ingelheim Animal Health

Ingelheim, Germany

Jonathan Grima

CHIEF SCIENTIFIC OFFICER, PURMINDS NEUROPHARMA INC.

PurMinds NeuroPharma Inc.

Toronto, Ontario,

Jonathan Grinstein

SENIOR SCIENCE EDITOR, GEN

Delivering on the next mRNA-based breakthroughs

Troy Groetken, JD;LLM;RPh

SHAREHOLDER/BOARD MEMBER, MCANDREWS, HELD & MALLOY

The Roles of AI and Big Data in Precision Healthcare: Perspectives from the Drug Development Pathway and the Patient Journey

Chicago, Illinois, United States

Kevin Grogan

MANAGING EDITOR, SCRIP INTELLIGENCE

Deal-Making in the Current Environment: A Fireside Chat with Alban de La Sablière, Head of Partnering, Sanofi

Manchester, United Kingdom

Moira Gunn, PhD

RADIO PROGRAM HOST, TECH NATION

Ending The Cycle of Chronic Disease: Leveraging New Therapeutic Approaches with Disease-Modifying Potential

San Francisco, California, United States

Jon Gunther, MBA;PhD

VICE PRESIDENT, BUSINESS DEVELOPMENT, JUST-EVOTEC BIOLOGICS

Interview with Jon Gunther

Seattle, Washington, United States

Anjali Gupta, MBA;PhD

BUSINESS DEVELOPMENT, AXIOM SPACE

Space & Microgravity as an Innovation Platform for R&D

San Diego, California, United States

Pam Guthrie

DIRECTOR, SALES AND MARKETING, CLINCIERGE

Participant Sensitivity: Amplifying the Voice of the Patient in Clinical Trials

Philadelphia, Pennsylvania, United States

Kimberly Ha

CEO, KKH ADVISORS

Next Gen Oncology Therapeutics: Changing the Cancer Landscape

Carolina, Puerto Rico, United States

Yacoub Habib, MBA;PhD

CEO, OPHIDION, INC.

Ophidion, Inc.

Bethlehem, Pennsylvania, United States

Daniel Haders II, PhD

CEO, MODEL MEDICINES

Model Medicines

La Jolla, California, United States

Todd Haim, PhD

CHIEF, OFFICE OF STRATEGIC EXTRAMURAL PROGRAMS, NIA, NATIONAL INSTITUTES OF HEALTH (NIH)

Fostering Diversity and Bio-Equity Through Novel Financing and Training Initiatives in the Aging Innovation Ecosystem

Bethesda, Maryland, United States

Sonia Hall, PhD

PRESIDENT & CEO, BIOKANSAS

How Academia, Industry, Government, & Nonprofit Organizations Advance Science

Shawnee Mission, Kansas, United States

Tom Hallam, PhD

CHIEF EXECUTIVE OFFICER, PALISADE BIO

Palisade Bio

Carlsbad, California, United States

Tae Han

PRESIDENT AND COO, PROFOUNDBIO

Showcase of Emerging Innovative Companies, Part 2

Woodinville, Washington, United States

Kyuho Han, PhD

CEO/FOUNDER, MEDIC LIFE SCIENCES

MEDIC Life Sciences

San Carlos, California, United States

Elie Hanania

VICE PRESIDENT, PD, VIRAL VECTOR TECHNOLOGIES, AVID BIOSERVICES, INC.

Partnering with a CDMO - Past the Service Offering

Tustin, California, United States

Carl Hansen

CEO, ABCELLERA BIOLOGICS

AbCellera

Vancouver, British Columbia, Canada

John Harkness

CEO, REWIRE NEURO, INC.

Rewire Neuro, Inc

Portland, Oregon, United States

Todd Harnett

EXECUTIVE DIRECTOR, HEAD OF NORTH AMERICA DELIVERY, THREAD

How Digital Health Technical Innovation is Driving Decentralized Clinical Trial Success

Tustin, California, United States

Molly Harper

CHIEF BUSINESS OFFICER, SYNLOGIC

Synlogic, Inc

CAMBRIDGE, Massachusetts, United States

David Harris

PRESIDENT, CLINCIERGE

Participant Sensitivity: Amplifying the Voice of the Patient in Clinical Trials

Philadelphia, Pennsylvania, United States

Paul Hastings

PRESIDENT & CEO, NKARTA THERAPEUTICS, INC.

Fireside Chat: A Discussion on the Orphan Drug Revolution

Wednesday: BIO Chair Remarks

Improving Disparity Begins with Us: Biotech Leaders Drive Diversity, Equity and Inclusion in Healthcare

South San Francisco, California, United States

Jeff Hatfield

CEO, VIVIDION THERAPEUTICS

Cultivating innovation post acquisition: Bayer and Vividion’s arm’s length model

San Diego, California, United States

Shin Hatou, MD;PhD

CEO, CELLUSION INC.

Cellusion Inc.

Chuo-ku, Japan

Marc Hedrick

PRESIDENT AND CEO, PLUS THERAPEUTICS

Plus Therapeutics

Austin, Texas,

Karen Heidelberger, MBA

CHIEF PARTNERSHIP AND COMMUNICATIONS OFFICER & PARTNER, DEERFIELD MANAGEMENT COMPANY LP

Fostering Diversity and Bio-Equity Through Novel Financing and Training Initiatives in the Aging Innovation Ecosystem

New York, New York, United States

James Helliwell, FRCP;MD

CEO, EUPRAXIA PHARMACEUTICALS INC.

Eupraxia Pharmaceuticals

Victoria, British Columbia, Canada

Matthew Henn, PhD

EXECUTIVE VICE PRESIDENT, CHIEF SCIENTIFIC OFFICER, SERES THERAPEUTICS

Gut Check: Current Trends in Microbiome Therapeutics Development

Cambridge, Massachusetts, United States

Colonel (Ret.) Matthew Hepburn, MD

DIRECTOR OF COVID VACCINE DEVELOPMENT, DEPARTMENT OF DEFENSE COUNTERMEASURES ACCELERATION GROUP

Stopping the Next Pandemic Before it Starts: What We’ve Learned

Getting to 100 Days: Driving Vaccine Innovation Between Pandemics

The Silent Pandemic: Tackling Antimicrobial Drug Resistance (AMR)

Washington,

Chris Hibberd

, NUCLEIX, INC.

The Future for Liquid Biopsy and Cancer Detection

San Diego, California, United States

Carolyn Hickey

EXECUTIVE DIRECTOR, GOVERNMENT AFFAIRS & POLICY, SAREPTA THERAPEUTICS, INC.

Calculating the Value and Impact of Accelerated Approvals

Cambridge, Massachusetts, United States

Colin Hill

CHIEF EXECUTIVE OFFICER, GNS HEALTHCARE

Why the FDA Will Bet More on in Silico Simulations To Trigger Better Success Rates for NDAs

Somerville, Massachusetts, United States

Kate Hillier, JD

PARTNER, COOLEY

Monetizing AI & Machine Learning Applications in Life Sciences

Seattle, Washington,

Mellanie Hills

CEO, STOPAFIB.ORG

Exploring Factor XI: A Paradigm Shift as a Hemostasis Sparing Anticoagulant

Greenwood, Texas, United States

Jonathan Hirsch

INVESTOR, MULTIPLE

Artificial Intelligence and Machine Learning: Case Studies in Rare Disease Drug Development

New City, New York, United States

Piret Hirv

MS, CONNECTED HEALTH CLUSTER

Estonia

Tallinn, Estonia

Steffan Ho, MD;PhD

VICE PRESIDENT AND HEAD OF TRANSLATIONAL ONCOLOGY, PFIZER CONSUMER GROUP

Why the FDA Will Bet More on in Silico Simulations To Trigger Better Success Rates for NDAs

San Diego, California, United States

Yao Ho, MBA

MANAGING DIRECTOR, LYFE CAPITAL

To Invest or Not to Invest, Cross-Border Investments in the Age of Rising Global Uncertainties

Menlo Park, California, United States

Vera Hoffman

CEO, REVEAL PHARMA

Reveal Pharmaceuticals Inc

Cambridge, Massachusetts, United States

Dorothy Hoffman, MPP

EXTERNAL ENGAGEMENT LEAD, HEALTHCARE INNOVATION CENTER, PFIZER

Value-Based Pledge (VBP): Patients at the Center of Value-Based Arrangements With Manufacturers

New York, New York, United States

Ben Hohn, MBA

PRINCIPAL -- BD, PIPELINE AND LAUNCH STRATEGY & EMERGING PHARMA LEAD, ZS ASSOCIATES

Out-License, Co-Promote, or Solo-First launch? Insights From an Expert Panel and a Decade of U.S. and EU First-Launch and Partnering Data

Princeton, New Jersey, United States

Michele Holcomb, PhD

EVP, STRATEGY & BUSINESS DEVELOPMENT OFFICER, CARDINAL HEALTH

Value-Based Pledge (VBP): Patients at the Center of Value-Based Arrangements With Manufacturers

Dublin, Ohio, United States

Ben Holmes

CEO, NANOCHON

Nanochon

Burke, Virginia, United States

Nancy Hong, PhD

MANAGING DIRECTOR, RIVERVEST VENTURE PARTNERS

Improving Disparity Begins with Us: Biotech Leaders Drive Diversity, Equity and Inclusion in Healthcare

San Diego, California, United States

Thomas Hoover

CHIEF BUSINESS OFFICER, MATINAS BIOPHARMA, INC.

Matinas Biopharma

Concord, Massachusetts, United States

Eric Horler, MBA

PRESIDENT AND CEO, AIQ SOLUTIONS, INC.

AIQ Solutions

Madison, Wisconsin, United States

Paul Howard Howard, PhD

SENIOR DIRECTOR OF PUBLIC POLICY, AMICUS THERAPEUTICS, INC.

Where Do We Go from Here? Optimizing America’s Health Care Strategy for Advancing Responsible AI

Artificial Intelligence and Machine Learning: Case Studies in Rare Disease Drug Development

Philadelphia, Pennsylvania, United States

Edward Hsieh

R&D VP PH.D., FORMOSA LABORATORIES, INC.

Formosa Laboratories

Taoyuan, Taiwan

Felix Hsu

SR. VICE PRESIDENT, US OPERATIONS & GLOBAL BUSINESS DEVELOPMENT, WUXI APPTEC

Therapeutic Cell and Gene Therapy Modalities - Business and Manufacturing Strategies Impacting the Decision to Develop One Therapy Type vs. Another

Saint Paul, Minnesota, United States

Wei Chiao Huang

DIRECTOR, VACCINE DEVELOPMENT, POP BIOTECHNOLOGIES

POP Biotechnologies

Buffalo, New York,

Bolyn Hubby, PhD

EVP AND CHIEF CORPORATE AFFAIRS OFFICER, VIR BIOTECHNOLOGY, INC.

The Future of Flu Protection: Novel Influenza Technologies

San Francisco, California, United States

Matthew Hudes

CEO, BDLBIOLOGX

Protecting Your Global Assets

Vancouver, Washington, United States

Brady Huggett

ENTERPRISE EDITOR, SIMONS FOUNDATION

“Hope Lies in Dreams”—Ionis’s Stan Crooke and the First Drug for SMA Patients

New York, New York, United States

Richard Hughes IV

PROFESSORIAL LECTURER IN LAW, THE GEORGE WASHINGTON UNIVERSITY LAW SCHOOL

Vaccine Innovation and the Future of Life-Course Immunization

Washington, District of Columbia, United States

Michael Humbert

CO-FOUNDER, NATURE'S TOOLBOX

Nature's Toolbox

Rio Rancho, New Mexico, United States

Brenda Huneycutt, JD;MPH;PhD

DIRECTOR, GLOBAL REGULATORY POLICY, MERCK

COVID-19 360°: Embedding Global Best Practices in Routine Regulatory Action and Preparing for the Next Pandemic

Rockville, Maryland, United States

Lori Hunt

EXECUTIVE DIRECTOR, AMGEN

Harnessing the Power of Biotechnology on ESG Issues

Newbury Park, California, United States

Melissa Hunt

OF DIRECTOR OF THE BUREAU OF METABOLISM, ONCOLOGY AND REPRODUCTIVE SCIENCES WITHIN THE PHARMACEUTICAL DRUGS DIRECTORATE, HEALTH CANADA

International Regulatory Strategy: Impact of ORBIS

Albert Hwang

MANAGING DIRECTOR, MORGAN STANLEY

Realizing the Promise of Gene Therapy: Current Challenges, Opportunities and Trends

New York, New York, United States

Jangyoun Hwang, PhD

TEAM MANAGER, FUTURE MEDICINE CO., LTD.

Future Medicine Co., Ltd.

Seongnam, Korea, Republic of

Melanie Igwe

CO-FOUNDER AND COO, DRUG VIU

Solving the Founder/Funder Conundrum to Drive Health Equity and Support Marginalized Communities

Sin-Hyeog Im

CEO, IMMUNOBIOME

ImmunoBiome

Pohang, Korea, Republic of

Cynthia Isaac

MANAGING DIRECTOR, SYNEOS HEALTH

Solving the Founder/Funder Conundrum to Drive Health Equity and Support Marginalized Communities

Brooklyn, New York, United States

Mandy Jackson

MANAGING EDITOR, SCRIP INTELLIGENCE

Joining forces to accelerate innovation in neuroscience

Changing the Paradigm: Expanding Access to Oncology Medicines

La Mesa, California, United States

Brianne Jahn

CBO, LIANBIO

Overcoming Complications in Cross-Border Licensing Deals with China

Princeton, New Jersey, United States

Adam James

MR., FBI

Protecting Your Global Assets

San Diego, California, United States

Catriona Jamieson, MD;PhD

DIRECTOR, SANFORD STEM CELL CLINICAL CENTER; DIRECTOR, CIRM ALPHA STEM CELL CLINIC; CHIEF, DIVISION, UNIVERSITY OF CALIFORNIA, SAN DIEGO

Space & Microgravity as an Innovation Platform for R&D

La Jolla, California, United States

Jessica Jensen

VICE PRESIDENT, CUSTOMER OPERATIONS AND INTEGRATION, SPACEX

International Space Station Astronauts at Work: Rocketing Biotechnology R&D to the Next Level

Hawthorne, California, United States

Rahul Jerath

SENIOR DIRECTOR, BD&A, ABBVIE

Wisdom and Wagers: Perspectives from Big Pharma Dealmakers

N. Chicago, Illinois, United States

RUHONG JIANG Sr.

CEO, ASC THERAPEUTICS.INC

Showcase of Emerging Innovative Companies, Part 2

Milpitas, California, United States

Sarah Jims

PRINCIPAL, TRIANGLE INSIGHTS GROUP, LLC

Which Shots, What Goal, and Who Should Shoot? Developing a Sustainable Portfolio for Cell and Gene Therapy Platforms

Durham, North Carolina, United States

Charley John, PharmD

DIRECTOR, HEALTHCARE POLICY & STRATEGY, WALGREEN CO.

Vaccine Innovation and the Future of Life-Course Immunization

Washington, District of Columbia, United States

Stefanie Johns

CHIEF SCIENTIFIC OFFICER, HOTH THERAPEUTICS, INC.

Hoth Therapeutics, Inc

New York, New York, United States

Sabrina Johnson

PRESIDENT & CEO, DARé BIOSCIENCE

Daré Bioscience

San Diego, California, United States

Tesheia Johnson, MBA;MHS

DEPUTY DIRECTOR AND CHIEF OPERATING OFFICER, YCCI; DIRECTOR OF CLINICAL RESEARCH, YSM, YALE UNIVERSITY

Diversity and Inclusion in Clinical Trials: Concrete Strategies for Enhancing Health Equity

New Haven, Connecticut, United States

Russell Jones, CPA

PARTNER, DELOITTE

Protecting Your Global Assets

San Francisco, California, United States

Charlotte Jones-Burton

SENIOR VICE PRESIDENT OF PRODUCT DEVELOPMENT AND STRATEGY, CHINOOK THERAPEUTICS

Best Practices for Building an Inclusive Biotech Company

Alex Jung

PRINCIPAL, ERNST & YOUNG, LLP

Value-Based Pledge (VBP): Patients at the Center of Value-Based Arrangements With Manufacturers

Chicago, Illinois,

David Kabakoff, PhD

EXECUTIVE PARTNER, SOFINNOVA INVESTMENTS

Next Gen Oncology Therapeutics: Changing the Cancer Landscape

La Jolla, California, United States

Sanjay Kakkar, MD;MPH;MSc

PRESIDENT & CEO, TRANQUIS THERAPEUTICS

Tranquis

Redwood City, California, United States

Lord Kakkar

PRESIDENT, THROMBOSIS RESEARCH INSTITUTE IN LONDON

Exploring Factor XI: A Paradigm Shift as a Hemostasis Sparing Anticoagulant

Anissa Kalinowski, MBA;MSc

CEO, HALO BIOSCIENCES

Halo Biosciences

Palo Alto, California, United States

Anuj Kalsy

SCIENTIFIC DIRECTOR, PRECISION MEDICINE GROUP

Precision for Medicine

Norton, Massachusetts, United States

Petrina Kamya

BUSINESS DEVELOPMENT DIRECTOR, INSILICO MEDICINE US, INC.

Targeting Aging Pathways To Treat Chronic Disease

New York, New York, United States

Sukmo Kang, DVM;PhD

DIRECTOR, BIOTOXTECH

BTT Groups

Cheongju-si, Korea, Republic of

SangWon Kang, PhD

CEO, VASTHERA CO.LTD.

Vasthera Co., Ltd

Seoul, Korea, Republic of

Byoung Cheol Kang

VICE PRESIDENT, MIRIMGENE CO. LTD.

MirimGene Co., Ltd.

Incheon, Korea, Republic of

Vik Kashyap

CEO, TOI LABS, INC.

Advancing and Commercializing Longevity Market Innovations — Leveraging Seed Funding, Foundational, and Accelerator Support To Advance Innovations for Older Adults

San Francisco, California, United States

Konstantina Katcheves

SENIOR VICE PRESIDENT, STRATEGY & BUSINESS DEVELOPMENT, BRISTOL MYERS SQUIBB

Navigating Asia-Pacific Innovation Deal Opportunities

What Happens When Your AI Identifies the Next Big Drug Candidate? Filing for a Patent May Not Be It.

Ellicott City, Maryland, United States

Heidi Kay, PhD

CEO, JERICHO SCIENCES, LLC

Jericho Sciences LLC

Durham, North Carolina, United States

Syed Kazmi, MBA;PhD

PRESIDENT & CHIEF EXECUTIVE OFFICER, JUBILANT THERAPEUTICS, INC.

Trends, Challenges and Opportunities of Epigenetic Therapeutics in Cancer

Bedminster, New Jersey, United States

Kenneth Kehl

MD, MPH, DANA-FARBER CANCER INSTITUTE

AACR Project GENIE: Powering Precision Medicine Through an International Consortium and a Pre-Competitive Collaboration With the Biopharmaceutical Industry

Wellesley Hills, Massachusetts, United States

Hans Keirstead

CHAIRMAN & CEO, AIVITA BIOMEDICAL, INC.

AIVITA Biomedical, Inc.

Irvine, California, United States

Danielle Kerkovich, PhD

DIRECTOR OF RESEARCH DEVELOPMENT AND PARTNERSHIPS, INTERNATIONAL FIBRODYSPLASIA OSSIFICANS PROGRESSIVA ASSOCIATION

Partnering for Progress: Collaborating With Patient Organizations To Advance Therapy Development and Maximize Patient Benefit

Spring, Texas, United States

Randolf Kerschbaumer

CEO, ONCOONE

OncoOne

Klosterneuburg, Austria

John Kerwin

TECHNICAL HEAD, GENE THERAPY, RESILIENCE

Current Realities of Make vs. Buy For Advanced Therapies in Manufacturing

La Jolla, California, United States

Ruhi Khan

CHIEF BUSINESS OFFICER, CARIBOU BIOSCIENCES, INC.

Realizing the Promise of Gene Therapy: Current Challenges, Opportunities and Trends

Berkeley, California, United States

Anjalee Khemlani

SENIOR REPORTER, YAHOO FINANCE

Stopping the Next Pandemic Before it Starts: What We’ve Learned

New York, New York, United States

Amal Khouri

CHIEF BUSINESS OFFICER, KNIGHT THERAPEUTICS INC.

Knight Therapeutics Inc.

MONTREAL, Quebec, Canada

Mark Kiel, MD;PhD

FOUNDER, CSO, GENOMENON

Genomenon

Ann Arbor, Michigan, United States

Weston Kightlinger

DIRECTOR, CELL-FREE PROTEIN SYNTHESIS, RESILIENCE

Enabling Next-Generation Biomanufacturing Using Cell-free Technology

La Jolla, California, United States

Sarah Kilpatrick, MBA

BUSINESS DEVELOPMENT GROUP LEAD, INTERNAL MEDICINE AND VACCINES, PFIZER

Wisdom and Wagers: Perspectives from Big Pharma Dealmakers

Yongchan Kim

FOUNDER AND CEO, TERAIMMUNE, INC.

TeraImmune, Inc.

Gaithersburg, Maryland,

MINSEOK KIM, MD

MANAGER OF STRATEGY AND LICENSING, ADEL, INC.

Adel, Inc.

Seoul, Korea, Republic of

Thomas Kim, JD

CEO, EPIVARIO

EpiVario Inc

Philadelphiaa, Pennsylvania, United States

Helen Kim, PhD

EXECUTIVE DIRECTOR, EXTERNAL R&D, AMGEN INC.

Amgen Inc.

Thousand Oaks, California, United States

Jinwoo Kim

CEO, HAII

HAII corp.ltd

Seoul, Korea, Republic of

Jeonghan Kim

MANAGING DIRECTOR, CURACLE CO., LTD.

CURACLE

Seongnam-si, Korea, Republic of

Charlie Kim, PhD

HEAD OF MOLECULAR SCIENCE, VERILY

Defining Correlates of Protection for COVID-19: The Technology is Here, The Time is Now

South San Francisco, California, United States

Ikebeom Kim, MS

CHIEF BUSINESS OFFICER, RECUON

Recuon

Seoul, Korea, Republic of

Roy Kimura, PhD

CEO, MODULUS DISCOVERY, INC.

Modulus Discovery, Inc.

Cambridge, Massachusetts, United States

Ivan King, PhD, MD

EXECUTIVE VICE PRESIDENT OF CLINICAL OPERATIONS, HINOVA

Showcase of Emerging Innovative Companies, Part 1

Stephen Kingsmore, MD

PRESIDENT/CEO, RADY CHILDREN'S INSTITUTE FOR GENOMIC MEDICINE

Advancing Policies to Shorten the Rare Disease Patient’s Diagnostic Journey

Matthew Kinn

SVP, RECURSION

Buying into tomorrow’s drug platforms

Salt Lake City, Utah, United States

Peter Klinken

CHIEF SCIENTIST OF WESTERN AUSTRALIA, CHIEF SCIENTIST OF WESTERN AUSTRALIA

Innovation and Access: What COVID-19 Therapeutics Can Teach Us About Preparing for the Next Pandemic

Perth, Western Australia, Australia

Jak Knowles, MD

CO-FOUNDER, PRESIDENT, & CEO, AFFINI-T THERAPEUTICS

Affini-T Therapeutics

Watertown, Massachusetts, United States

Donald Kohn, MD

PROFESSOR, UNIVERSITY OF CALIFORNIA, LOS ANGELES

Gene Therapy Pioneers Discuss What's Next for Gene Therapy

Safety Aspects of AAV- and Lentivirus-based Cell and Gene Therapy

Los Angeles, California,

Neal Koller

CHAIRMAN & CEO, ALPHYN BIOLOGICS, LLC

Alphyn Biologics, Inc.

Annapolis, Maryland, United States

Anja Krammer

CHIEF EXECUTIVE OFFICER, TURN BIOTECHNOLOGIES

Turn Biotechnologies

San Francisco, California, United States

Michael Krams

CHIEF QUANTITATIVE MEDICINE OFFICER, EXSCIENTIA

The New Journey of a Data Point: Digital Innovation for a Powerful Purpose

OXFORD, United Kingdom

Jenelle Krishnamoorthy, PhD

VICE PRESIDENT, HEAD OF GLOBAL PUBLIC POLICY, CORPORATE AFFAIRS, MERCK

Innovation and Access: What COVID-19 Therapeutics Can Teach Us About Preparing for the Next Pandemic

Kenilworth, New Jersey, United States

Arthur Kuan

CEO, CG ONCOLOGY, INC.

Next Gen Oncology Therapeutics: Changing the Cancer Landscape

Irvine, California, United States

Yoshi Kumagai

PRESIDENT AND CEO, ORTHOTROPHIX, INC.

OrthoTrophix, Inc.

Foster City, California, United States

Seema Kumar

SVP, JOHNSON & JOHNSON

Future of Biotech

New Brunswick, New Jersey, United States

Hayato Kume

FIRST SECRETARY, EMBASSY OF JAPAN

Innovation and Access: What COVID-19 Therapeutics Can Teach Us About Preparing for the Next Pandemic

Washington, District of Columbia, United States

Naheed Kurji

PRESIDENT AND CEO, CYCLICA, INC

Where Do We Go from Here? Optimizing America’s Health Care Strategy for Advancing Responsible AI

Toronto, Ontario, Canada

Xavier Kurz

MD, EUROPEAN MEDICINES AGENCY (EMA)

Is Real-world evidence used optimally in regulatory decision-making?

COVID-19 360°: Embedding Global Best Practices in Routine Regulatory Action and Preparing for the Next Pandemic

Amsterdam, Netherlands

Edwin Kwon

CHIEF FINANCIAL OFFICER, EUTILEX

Eutilex Co., Ltd.

Seoul, Korea, Republic of

Darius Lakdawalla, PhD

QUINTILES CHAIR IN PHARMA DEV & REG INNOVATION, UNIVERSITY OF SOUTHERN CALIFORNIA

Enabling and Supporting Efficacy-Linked Pricing Contracts

Los Angeles, California, United States

Janet Lambert

CEO, ALLIANCE FOR REGENERATIVE MEDICINE

Realizing the Promise of Gene Therapy: Current Challenges, Opportunities and Trends

Washington, District of Columbia, United States

Jordan Lancaster, PhD

CHIEF EXECUTIVE OFFICER, AVERY THERAPEUTICS, INC.

Avery Therapeutics, Inc.

Tucson, Arizona, United States

Pepper Landson

CO-FOUNDER / CEO, PRAETEGO, INC.

Praetego Inc

Durham, North Carolina, United States

Mark Lappe

CHIEF EXECUTIVE OFFICER, INHIBRX

Navigating an IPO: Are Crossover Rounds Still Needed To Make a Deal Float?

La Jolla, California, United States

Camille Laturno

VP, COMMERCIAL PRODUCT LAW & CHIEF PRIVACY OFFICER, GLOBAL BLOOD THERAPEUTICS

Is this the End of Global Clinical Trials? How to Navigate Data Privacy and National Security Restrictions Affecting Cross-Border Data Transfers in the EU and China

South San Francisco, California, United States

Serge Lauriou

CTO, NSW GOVERNMENT

My Medic Watch Pty Ltd

Sydney, New South Wales, Australia

Donna LaVoie

PRESIDENT & CEO, LAVOIEHEALTHSCIENCE

How to Tell Your Story in 15 Slides

Boston, Massachusetts, United States

Olivier Leclerc

SENIOR PARTNER, MCKINSEY & COMPANY

Funding Transformational Platforms: Sustaining Development of Next Generation Medicines in a Challenging Market

Los Angeles, California, United States

Seth Lederman, MD

CHIEF EXECUTIVE OFFICER, TONIX PHARMACEUTICALS, INC

Tonix Pharmaceuticals

Chatham, New Jersey, United States

Yongsun Lee, PhD

CHIEF STRATEGY OFFICER, S-ALPHA THERAPEUTICS, INC.

S-Alpha Therapeutics, Inc

Seoul, Korea, Republic of

Sang Hoon Lee, PhD

CEO/FOUNDER, ABL BIO

Navigating Asia-Pacific Innovation Deal Opportunities

Pangyo, Korea, Republic of

Hongwon Lee, PhD

CTO, PROTEINA CO., LTD.

PROTEINA Co., Ltd.

Seoul, Korea, Republic of

Hanyong Lee

DIRECTOR, OLIPASS CORPORATION

OliPass Corporation

Gyeonggido, Korea, Republic of

JayJay Lee

CEO, FATIABGEN CO., LTD.

Fatiabgen Bioscience Korea

Sejong,

Tsipi LEHRER III, PhD

HEAD OF BUSINESS DEVELOPMENT AND STRATEGIC ADVISOR, BIOLINERX, LTD

Out-License, Co-Promote, or Solo-First launch? Insights From an Expert Panel and a Decade of U.S. and EU First-Launch and Partnering Data

Modi'in, Israel

Julianna LeMieux, PhD

SENIOR SCIENCE WRITER, GENETIC ENGINEERING & BIOTECHNOLOGY NEWS

A New Era in Gene Therapy

New Rochelle, New York, United States

Susan Lenderts

SENIOR DIRECTOR, US LIFE SCIENCES, SAS INSTITUTE, INC.

Advancing the landscape of drug repurposing: Diverse perspectives and solutions from the field

Cary, North Carolina, United States

Rachael Lester, MBA

SVP, BUSINESS DEVT & CORP STRATEGY, HARPOON THERAPEUTICS

Early Scientific and Clinical Strategy for Optimizing Value Inflection in Oncology Financing and Dealmaking

South San Francisco, California, United States

Michael Levene

CO-CEO, APPLIKATE TECHNOLOGIES

Applikate Technologies

Washington, District of Columbia, United States

Melanie Levy

MEMBER, MINTZ, LEVIN, COHN, FERRIS, GLOVSKY & POPEO, PC

Navigating an IPO: Are Crossover Rounds Still Needed To Make a Deal Float?

Boston, Massachusetts, United States

Sheri Lewis

EXECUTIVE VICE PRESIDENT, GLOBAL OPERATIONS & SUPPLY CHAIN, AVANTOR

Supply chain crisis: forward looking solutions

Ivy Lewis

JUNIOR BIOGENEIUS FINALIST

Future of Biotech

Lily Li

PRINCIPAL, NORTHPOND VENTURES

Persuasive Pitching – Do You Have the Talent to Engage Investors?

San Francisco, California, United States

Ji Li, PhD

PRESIDENT, AFFAMED THERAPEUTICS

Navigating Asia-Pacific Innovation Deal Opportunities

New York, New York, United States

Michelle Li

GLOBAL VACCINES BUSINESS DEVELOPMENT, MERCK

Wisdom and Wagers: Perspectives from Big Pharma Dealmakers

Kenilworth, New Jersey, United States

Ivan Liachko, PhD

CEO, PHASE GENOMICS, INC.

Phase Genomics, Inc.

Seattle, Washington, United States

Emmanuel Ligner

VP AND GROUP EXECUTIVE BIOTECHNOLOGY, CYTIVA

Interview with Emmanuel Ligner

Marlborough, Massachusetts, United States

Han Lim

VP OF BUSINESS OPERATIONS, DEEPCURE

DeepCure

Berkeley, California, United States

Han Liang Lim

CSO, COASTAR THERAPEUTICS, INC.

Coastar Therapeutics Inc.

San Diego, California, United States

Yanhong Lin

MANAGING PARTNER, CTIC CAPITAL

China Summit Welcome Remarks

To Invest or Not to Invest, Cross-Border Investments in the Age of Rising Global Uncertainties

San Jose, California, United States

Robert Lindberg, PhD

VICE PRESIDENT, SCIENCE & TECHNOLOGY, NORTH CAROLINA BIOTECHNOLOGY CENTER

Impactful Models and Resources for De-risking and Translating University-Held Innovations

Research Triangle, North Carolina, United States

Kjell Lindgren, MD

CREW-4 MISSION COMMANDER, NASA ASTRONAUT, NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (NASA)

International Space Station Astronauts at Work: Rocketing Biotechnology R&D to the Next Level

Lyndsey Linke, MEng;PhD

CEO & CO-FOUNDER, SIVEC BIOTECHNOLOGIES

SiVEC Biotechnologies

Fort Collins, Colorado, United States

Jason Litten, MD

CLINICAL CONSULTANT, ARTIVA BIOTHERAPEUTICS

Which Shots, What Goal, and Who Should Shoot? Developing a Sustainable Portfolio for Cell and Gene Therapy Platforms

Poway, California, United States

Amy Liu

INVESTOR, MUBADALA CAPITAL- VENTURES

Faster and Stronger: How RNA Will Advance Precision Medicine and Accessibility

San Francisco, California, United States

Donald Lo, PhD

DIRECTOR, THERAPEUTIC DEVELOPMENT BRANCH, NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES (NCATS)

Impactful Models and Resources for De-risking and Translating University-Held Innovations

Rockville, Maryland, United States

Arturo Loaiza-Bonilla, MD

CO-FOUNDER, CHIEF MEDICAL ADVISER, MASSIVE BIO

The Roles of AI and Big Data in Precision Healthcare: Perspectives from the Drug Development Pathway and the Patient Journey

Neha Londono

DIRECTOR, CLINICAL TRIAL DIVERSITY AND INCLUSION, SEAGEN INC.

Equity by Design: Utility of a Metrics Framework and Metrics To Evaluate Progress on Diversity, Equity, and Inclusion in Clinical Research

Austin, Texas, United States

Henry Long

INSTITUTE SCIENTIST, DFCI

Trends, Challenges and Opportunities of Epigenetic Therapeutics in Cancer

Boston, Massachusetts, United States

Stephan Loose

CHIEF COMMERCIAL OFFICER, CERUVIA LIFESCIENCES, INC.

Ceruvia Lifesciences, Inc.

Greenwich, Connecticut, United States

Michael Lopez-Alegria

, AXIOMSPACE

International Space Station Astronauts at Work: Rocketing Biotechnology R&D to the Next Level

Houston, Texas, United States

James Lu, MD;PhD

CO-FOUNDER & CEO, HELIX

Partnering Strategies for Success in Digital Health

San Mateo, California, United States

Yun-Chi Lu

CEO, PRECISEMAB BIOTECH CO., LTD.

PrecisemAb Biotech Co., Ltd.

Taipei City, Taiwan

Kip Ludwig

ASSOCIATE PROFESSOR, UNIVERSITY OF WISCONSIN - MADISON

Bioelectronic Medicine: Beyond Biochemistry

Madison, Wisconsin, United States

Barbara Lueckel

GLOBAL HEAD, TECHNOLOGY PARTNERING, ROCHE

Maximizing the Potential of Platforms Through Creative and Effective Deal-Making Strategies

Basel, Switzerland

Scott Lundeen, PhD

SR. DIRECTOR, BUSINESS DEVELOPMENT, JOHNSON & JOHNSON

Cancer Trials Don’t Have To Fail 90% of the Time. Seriously.

Raritan, New Jersey, United States

Gregory Lyles

VICE PRESIDENT, MARKET ACCESS, AKILI INTERACTIVE LABS

Understanding the Reimbursement Landscape for Prescription Digital Therapeutics

Philadelphia, Pennsylvania, United States

M. Joe Ma

CEO, PAPIVAX

PapiVax Biotech, Inc.

Taipei City, Taiwan

Douglas MacDougall

MANAGING PARTNER, MACDOUGALL

Persuasive Pitching – Do You Have the Talent to Engage Investors?

Natick, Massachusetts,

Olivier Madec

GLOBAL HEAD OF M&A AND VENTURE INVESTMENTS, SERVIER EUROPE

Servier

Suresnes cedex, Ile-de-France, France

Eric Maeng

DIRECTOR, SOVARGEN

Sovargen.Co.Ltd

Seoul, Korea, Republic of

Leonardo Magneschi, PhD

HEAD OF MOLECULAR BIOLOGY, INGENZA LTD

Ingenza Ltd.

Edinburgh, United Kingdom

Larry Mahan

PRESIDENT, THE BIOTECHNOLOGY INSTITUTE

Future of Biotech

Washington, District of Columbia, United States

Nadir Mahmood, PhD

CHIEF FINANCIAL AND BUSINESS OFFICER, NKARTA THERAPEUTICS, INC.

How to Survive a Stormy Biotech Season: Thriving in a Challenging Market

South San Francisco, California, United States

Abdullah Mahmud

EXECUTIVE CHAIRMAN, HA TECH PTY LTD

HA TECH PTY LTD

Sydney, New South Wales, Australia

Christophe Maier

CEO, LAGOSTA SA

LAGOSTA SA

St-Prex, Vaud, Switzerland

Arpita Maiti, PhD

HEAD OF IMMUNOLOGY SEARCH & EVALUATION, ABBVIE INC.

AbbVie

North Chicago, Illinois, United States

Morena Makhoana

CEO, BIOVAC

Building Vaccine Manufacturing Capacity in Africa: A View From South African

Getting to 100 Days: Driving Vaccine Innovation Between Pandemics

Donald Manning

CHIEF MEDICAL OFFICER AND HEAD OF R&D, TRAVECTA THERAPEUTICS

Travecta Therapeutics

Singapore, Singapore

Upendra Marathi

CEO, 7 HILLS PHARMA LLC

7 Hills Pharma LLC

Houston, Texas, United States

Adam Margolin, PhD

VENTURE PARTNER, NEXTVIVO

NextVivo

Palo Alto, California, United States

Ross Margulies

PARTNER, FOLEY HOAG LLP

Understanding the Reimbursement Landscape for Prescription Digital Therapeutics

Washington, District of Columbia, United States

Peter Marks

DIRECTOR OF THE CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER), THE U.S. FOOD AND DRUG ADMINISTRATION

FDA Town Hall

Realizing the Promise of Gene Therapy: Current Challenges, Opportunities and Trends

Silver Spring, Maryland, United States

Daniela Marreco Cerqueira, PhD

DEPUTY DIRECTOR, FIFTH DIRECTORATE, NATIONAL HEALTH SURVEILLANCE AGENCY - ANVISA

Where Health Meets Policy: Addressing Gender Equity through Health

Brasilia, Brazil

Marc Martin-Casas

HEAD OF ILLUMINA ACCELERATOR, ILLUMINA ACCELERATOR

Illumina Accelerator

Foster City, California, United States

Sabrina Martucci Johnson

PRESIDENT AND CEO, DARé BIOSCIENCE, INC.

Primed for Growth: Innovating to Address the Business Opportunity to Build a Women’s Health Market

San Diego, California,

Neal Masia, PhD

CEO, ENTITYRISK, INC.

Enabling and Supporting Efficacy-Linked Pricing Contracts

Princeton, New Jersey, United States

Melanie Matheu, PhD

FOUNDER, CEO, PRELLIS BIOLOGICS

Prellis Biologics, Inc.

Hayward, California, United States

Osamu Matsuzaki

BOARD DIRECTOR, ASAHI KASEI PHARMA CORPORATION

Asahi Kasei Pharma

Tokyo, Japan

Soeren Mattke

PROFESSOR, UNIVERSITY OF SOUTHERN CALIFORNIA

Alzheimer’s: Tackling Scientific and Systemic Challenges to Change the Future of Alzheimer’s Care

Los Angeles, California, United States

Kelly Maynard

MRS, LITTLE HERCULES FOUNDATION

Female Founders: Paving the Way for Innovation and Equity

Dublin, Ohio, United States

Julianne McCall

CO-DIRECTOR OF PRECISION MEDICINE, CALIFORNIA GOVERNOR'S OFFICE OF PLANNING AND RESEARCH

Advancing Policies to Shorten the Rare Disease Patient’s Diagnostic Journey

Sacramento, California, United States

Robbie Mccarthy

US GENERAL MANAGER, ADVICENNE

Advicenne SA

Ardmore, Pennsylvania, United States

Charlie McDermott, MA;MBA

CHAIRMAN AND CEO, PRIMMUNE THERAPEUTICS

Primmune Therapeutics

Carlsbad, California, United States

Jess McDonough, PhD

VP BUSINESS DEVELOPMENT, ATTIVARE TX

Attivare Therapeutics

Natick, Massachusetts, United States

Tracie McGinnity, PhD

DR., CURIVA

Curiva

Chicago, Illinois, United States

Michelle McMurry-Heath, MD, PhD

PRESIDENT AND CEO, BIOTECHNOLOGY INNOVATION ORGANIZATION

Tuesday Keynote: BIO Unbound - Conversations Featuring Laura Deming, Dr. Kafui Dzirasa, Dr. Michelle McMurry-Heath, Dr. Alaa Murabit, and Dr. Siddhartha Mukherjee

Where Health Meets Policy: Addressing Gender Equity through Health

Improving Disparity Begins with Us: Biotech Leaders Drive Diversity, Equity and Inclusion in Healthcare

Washington, District Of Columbia, United States

Dennis McNamara

CEO, PYREFIN INC.

Pyrefin Inc.

Atlanta, Georgia, United States

Patrice McNicoll

CO-HEAD INVESTMENT BANKING, B. RILEY SECURITIES, INC.

Navigating an IPO: Are Crossover Rounds Still Needed To Make a Deal Float?

Jessica Mega, MD;MPH

CHIEF MEDICAL & SCIENTIFIC OFFICER AND CO-FOUNDER, VERILY LIFE SCIENCES, LLC

Fireside Chat with Jessica Mega, Chief Medical & Scientific Officer, Co-founder, Verily

South San Francisco, California, United States

Scott Megaffin

CEO, ADISO THERAPEUTICS

Adiso Therapeutics

Concord, Massachusetts, United States

Huseyin Mehmet

EXECUTIVE DIRECTOR, BRIDGE INNOVATION AND BUSINESS DEVELOPMENT, UMASS CHAN MEDICAL SCHOOL - WORCESTER, MA

How Academia, Industry, Government, & Nonprofit Organizations Advance Science

Worcester, Massachusetts, United States

Amit Mehta

VP, HEAD OF BUSINESS DEVELOPMENT, GENENTECH RESEARCH & EARLY DEVELOPMENT, GENENTECH

Genentech

South San Francisco, California,

Peter Meinke, PhD

CEO, TRI-INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTE

Feeding the Pipeline

New York, New York, United States

Thomas Meins

GLOBAL HEAD PROTEIN PRODUCTION HITS, WUXI APPTEC

Overcome costly Hit-finding challenges: Integrated platform for success

Heidi Meisenkothen

DIRECTOR, BUSINESS DEVELOPMENT AND STRATEGIC ALLIANCES, TEXAS BIOMEDICAL RESEARCH INSTITUTE

Speakers & Presenters